These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8078843)

  • 21. [The home treatment of deep venous thromboses with low-molecular-weight heparin].
    Grau Segura E; Real Vila E; Pastor Guzmán E; Torró Richart JA; Garay Burdeos M
    Rev Clin Esp; 1997 Jun; 197(6):398-401. PubMed ID: 9304129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-molecular-weight heparins for treatment of deep vein thrombosis.
    Chaffee BJ
    Am J Health Syst Pharm; 1997 Sep; 54(17):1995-9. PubMed ID: 9290899
    [No Abstract]   [Full Text] [Related]  

  • 23. Unfractionated versus low-molecular-weight heparin for deep venous thrombosis.
    Penner J
    N Engl J Med; 1996 Aug; 335(9):671; author reply 671-2. PubMed ID: 8692247
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of venous thromboembolism: unfractionated heparin or low molecular weight heparins?
    Agnelli G
    Haematologica; 1995; 80(2 Suppl):78-83. PubMed ID: 7628776
    [No Abstract]   [Full Text] [Related]  

  • 25. [The treatment of deep venous thrombosis using low-molecular heparin. Swiss Consensus Conference for the Application of Low-molecular Heparin].
    Bachmann F
    Schweiz Med Wochenschr; 1994 Feb; 124(5):169-78. PubMed ID: 8128198
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of a once daily with a twice daily subcutaneous low molecular weight heparin regimen in the treatment of deep vein thrombosis. FRAXODI group.
    Charbonnier BA; Fiessinger JN; Banga JD; Wenzel E; d'Azemar P; Sagnard L
    Thromb Haemost; 1998 May; 79(5):897-901. PubMed ID: 9609216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapy of venous thromboembolism with low-molecular-weight heparins].
    Haas S; Haas P; Creutzig A
    Vasa; 2000 Feb; 29(1):5-10. PubMed ID: 10731882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prophylaxis of postoperative thromboembolism. Randomized prospective study].
    Manso LC; Milheiro A; Castro e Sousa F
    Acta Med Port; 1996; 9(2-3):87-90. PubMed ID: 8967308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial.
    Mismetti P; Mille D; Laporte S; Charlet V; Buchmüller-Cordier A; Jacquin JP; Fournel P; Dutrey-Dupagne C; Decousus H;
    Haematologica; 2003 Jan; 88(1):67-73. PubMed ID: 12551829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of low-molecular-weight heparin and unfractionated heparin in treatment of deep vein thrombosis.
    Rodger M; Bredeson C; Wells PS; Beck J; Kearns B; Huebsch LB
    CMAJ; 1998 Oct; 159(8):931-8. PubMed ID: 9834718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aging and venous thromboembolism influence the pharmacodynamics of the anti-factor Xa and anti-thrombin activities of a low molecular weight heparin (nadroparin).
    Mismetti P; Laporte-Simitsidis S; Navarro C; Sié P; d'Azemar P; Necciari J; Duret JP; Gaud C; Decousus H; Boneu B
    Thromb Haemost; 1998 Jun; 79(6):1162-5. PubMed ID: 9657442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapeutic management of superficial venous thrombosis with calcium nadroparin. Dosage testing and comparison with a non-steroidal anti-inflammatory agent].
    Titon JP; Auger D; Grange P; Hecquet JP; Remond A; Ulliac P; Vaissié JJ
    Ann Cardiol Angeiol (Paris); 1994 Mar; 43(3):160-6. PubMed ID: 8024227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparative study of the efficacy of a low dose of antivitamin K and a preventive dose of low molecular weight heparin in the prevention of relapses of deep venous thrombosis after curative treatment in the aged subject].
    Pistorius MA; Said L; Planchon B
    J Mal Vasc; 1994; 19(1):68. PubMed ID: 8027686
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group.
    Koopman MM; Prandoni P; Piovella F; Ockelford PA; Brandjes DP; van der Meer J; Gallus AS; Simonneau G; Chesterman CH; Prins MH
    N Engl J Med; 1996 Mar; 334(11):682-7. PubMed ID: 8594426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Role of low molecular weight heparins for treating non-massive pulmonary embolism].
    Charbonnier B; Pacouret G
    Presse Med; 1994 Dec; 23(39):1821-5. PubMed ID: 7899306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost effectiveness of diagnosis of deep vein thrombosis in symptomatic patients.
    Hull RD; Feldstein W; Pineo GF; Raskob GE
    Thromb Haemost; 1995 Jul; 74(1):189-96. PubMed ID: 8578456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficacy of a very low molecular weight heparin fragment (CY 222) compared to standard heparin in patients with deep venous thrombosis. A randomized study].
    Faivre R; Neuhart E; Kieffer Y; Bassand JP; Maurat JP
    J Mal Vasc; 1987; 12 Suppl B():145-6. PubMed ID: 2834488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct comparison of enoxaparin and nadroparin in a rabbit model of arterial thrombosis prevention.
    Vlasin M; Dvorak M; Dvorakova M; Rauser P; Lexmaulova L; Gregor Z
    Thromb Res; 2010 Jul; 126(1):56-60. PubMed ID: 20382412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinically silent pulmonary embolism in patients with proximal deep venous thrombosis].
    Tomkowski W; Borowiec B; Burakowski J; Hajduk B; Filipecki S
    Pneumonol Alergol Pol; 1996; 64 Suppl 2():166-8. PubMed ID: 9181885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative study of the anticoagulant and anti-thrombotic effects of unfractionated heparin and a low molecular weight heparin (Fraxiparine) in an experimental model of human venous thrombosis.
    Diquélou A; Dupouy D; Cariou R; Sakariassen KS; Boneu B; Cadroy Y
    Thromb Haemost; 1995 Nov; 74(5):1286-92. PubMed ID: 8607111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.